Any AMD · general population
Vitamin E showed no clear difference in any AMD compared with placebo (high certainty).
1 finding from 1 review
Progression to late AMD (neovascular AMD, geographic atrophy or both) · general population
Vitamin E showed no clear difference in late AMD (either neovascular AMD or geographic atrophy or both) compared with placebo (moderate certainty).
1 finding from 1 review
Neovascular AMD · general population
It is very uncertain whether vitamin E changes neovascular AMD compared with placebo (very low certainty).
1 finding from 1 review
Geographic atrophy · general population
It is very uncertain whether vitamin E changes geographic atrophy compared with placebo (very low certainty).
1 finding from 1 review
Quality of life · general population
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse effects (AE) · general population
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Resource use and costs · general population
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All‐cause mortality · children under 5 years of age
1 finding from 1 review
Cause‐specific mortality · children under 5 years of age
1 finding from 1 review
Incidence rate radiologically confirmed first or only episode of pneumonia · children under 5 years of age
1 finding from 1 review
Hospital admissions · children under 5 years of age
1 finding from 1 review
TB cases · children under 5 years of age
1 finding from 1 review
Diarrhoea · children under 5 years of age
1 finding from 1 review
Malaria cases · children under 5 years of age
1 finding from 1 review
Febrile illness · children under 5 years of age
1 finding from 1 review
Intervention not reported
Vitamin C plus vitamin E(1 trial; 88 participants) · people with non‐alcohol‐related fatty liver disease (NAFLD)
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Intervention not reported
Amino acids plus vitamin C(1 trial; 191 participants) · people with non‐alcohol‐related fatty liver disease (NAFLD)
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Intervention not reported
Amino acids + vitamin C(1 RCT; 191 participants) · people with non‐alcohol‐related fatty liver disease (NAFLD)
It is very uncertain whether the intervention changes amino acids + vitamin C(1 RCT; 191 participants) (very low certainty).
1 finding from 1 review
OR 1.76 [0.62, 5.53]
Studies not reported
Very low
Intervention not reported
Vitamin C adherence · Various (pregnant women; daily smokers aged 16 and older; university students; children aged 5‐13)
1 finding from 1 review
Bleeding complications: 0.2 mg IM versus 0.5 mg IM · preterm infants
Higher dose vitamin K showed no clear difference in bleeding complications: 0.2 mg IM versus 0.5 mg IM compared with lower dose vitamin K (low certainty).
1 finding from 1 review